Retinal diseases

Clinical Trials

Below is a list of Retinal diseases clinical trials from the clinical trials database at Mayo Clinic.

Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
The purpose of this research study is to determine if ranibizumab is safe and is well tolerated when given in multiple doses for the treatment of neovascular (wet) age-related macular degeneration (AMD).
Read more

CRVO Regeneron
Intravitreal injection of the VEGF Trap for patients with macular edema due to CRVO will not be better than placebo.
Read more

The Age-Related Eye Disease Study 2 (AREDS2)
This study is being done to learn what role nutritional pills with lutein and zeaxanthin and/or omega-3 long-chain polyunsaturated fatty acids, specifically docosahexaenoic acid (DHA) and icosapentaenoic acid (EPA), play in preventing or slowing the development of age-related macular degeneration (AMD) and cataract.
Read more

Treatment Algorithms for Pigment Epithelial Detachments Treated with Intraocular Lucentis
The purpose of this study is to determine if there is a benefit to visual acuity (the sharpness of vision) with continued treatment of wet age-related macular degeneration (AMD) until retinal pigment epithelial detachment (RPED) fully resolves, to determine how long it takes for the swelling in the retina and then RPED to flatten following the initiation of Lucentis therapy, and to determine how
Read more